Advertisement

Topics

PerkinElmer Announces Financial Results for the Second Quarter of 2017

16:15 EDT 3 Aug 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
GAAP and adjusted revenues of $547 million GAAP earnings per share from continuing operations of $0.57; Adjusted earnings per share of $0.67 GAAP operating margins expand by 150 basis poi...

Other Sources for this Article

PerkinElmer, Inc.
Investor Relations:
Tommy J. Thomas, CPA, 781-663-5889
tommy.thomas@perkinelmer.com
or
Media:
Fara Goldberg, 781-663-5699
fara.goldberg@perkinelmer.com

NEXT ARTICLE

More From BioPortfolio on "PerkinElmer Announces Financial Results for the Second Quarter of 2017"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...